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Previews
ropoietic precursors (Huang et al., 2001 and references
therein). This inefficiency led Huang and colleagues to
hypothesize that the availability of an unknown factor
Quality Control of Receptor-Kinase
Signaling Complexes
could limit the expression levels of EpoR at the cell surface.
An obvious candidate for this factor was JAK2. In a series
of elegant experiments, Huang et al. demonstrated that
The erythropoietin receptor transduces signals lead- EpoR assembles with JAK2 while the receptor is still in
ing to the growth, differentiation, and survival of red the ER and that this assembly enhances receptor expres-
blood cell precursors via interaction with Janus kinase sion at the cell surface. The authors also mapped the
2 (JAK2). This interaction was thought to occur only interacting regions to a membrane-proximal segment of
at the plasma membrane. Recent evidence, however, the EpoR cytoplasmic domain and the amino-terminal JH7
shows that JAK2 assembles with newly synthesized (JAK homology 7) domain of JAK2 (see Figure). A JAK2
erythropoietin receptors in the endoplasmic reticulum, mutant devoid of kinase activity was still able to enhance
and that this assembly is essential for efficient expres- EpoR expression at the cell surface, indicating that the
sion of the receptors at the cell surface. effects of JAK2 were due to its ability to assemble with
the EpoR and not to its enzymatic activity.
Thus, in addition to serving as a signal transductionThe binding of many extracellular ligands such as hor-
molecule, JAK2 behaves as a true subunit of the EpoR,mones, growth factors, cytokines, and antigens to their
essential for optimal surface expression of the receptor-corresponding receptors on the cell surface triggers ac-
kinase complex. This is likely a manifestation of mecha-tivation of intracellular tyrosine kinases. Some receptors
nisms of quality control in the ER (Ellgaard et al., 1999).(e.g., the receptors for insulin, epidermal growth factor,
These mechanisms ensure that misfolded proteins orplatelet-derived growth factor, vascular endothelial
unassembled subunits of multiprotein complexes aregrowth factor, and nerve growth factor) have intrinsic
retained in the ER and are, in many cases, retrotranslo-tyrosine kinase activity within their cytoplasmic do-
cated into the cytosol for degradation by the ubiquitin-mains. Other receptors (e.g., the T and B cell antigen
proteasome pathway (Bonifacino and Weissman, 1998).receptors, immunoglobulin Fc receptors, and cytokine
It remains to be determined how EpoR lacking associ-receptors) do not possess intrinsic tyrosine kinase activ-
ated JAK2 is retained in the ER. One possibility is thatity but instead interact noncovalently with nonreceptor
the absence of JAK2 exposes a discrete determinanttyrosine kinases (e.g., Src family kinases and Janus fam-
within the cytoplasmic domain of EpoR that is recog-ily kinases) encoded by separate genes. These recep-
nized as an ER retention signal by a specific recognitiontors are thought to travel unaccompanied from their site
molecule. This would be analogous to the retention ofof synthesis in the endoplasmic reticulum (ER), through
the unassembled  subunit of the receptor for immuno-the secretory pathway and to the plasma membrane,
globulin E, which has a dilysine ER retrieval signal atwhere they encounter their partner tyrosine kinases,
the end of its cytoplasmic domain. Assembly with thewhich have been synthesized in the cytoplasm. In this
 subunit of this receptor masks the signal and releasesscenario, the kinases are not required for the biosyn-
the receptor from the ER (Letourneur et al., 1995). Thethetic transport of the receptors to the plasma mem-
EpoR, however, lacks a dilysine signal, and extensive
brane, and do not form obligatory stoichiometric com-
mutagenesis of its JAK2 binding segment failed to reveal
plexes with the receptors. Although this model of
any other ER retention signal (Huang et al., 2001). An
assembly and transport may apply to some receptors, alternative possibility favored by the authors is that the
a study by Huang et al. published in the December issue absence of JAK2 causes the EpoR cytoplasmic domain
of Molecular Cell reveals a startling new possibility. This to misfold, leading to recognition of this more global
report shows that the nonreceptor tyrosine kinase, Ja- conformational change by the ER quality control ma-
nus kinase 2 (JAK2), binds to the newly synthesized chinery. In this model, JAK2 would assist in the folding
erythropoietin receptor (EpoR) in the ER and promotes of the EpoR cytoplasmic domain. This concept should
its transport to the plasma membrane. open up a new avenue of inquiry into the mechanisms
The EpoR is a member of the cytokine receptor family that sense protein misfolding on the cytoplasmic face
and plays a critical role in the development of red blood of the ER membrane.
cells (Constantinescu et al., 1999). Binding of a single The EpoR-JAK2 complex may represent a paradigm
erythropoietin (Epo) molecule causes either association for the biogenetic liaisons of at least a subset of recep-
of two EpoR monomers or a conformational change of a tors with their tyrosine kinase partners. Huang et al.
preexisting EpoR homodimer (Wilson and Jolliffe, 1999; provide a glimpse at the generality of this phenomenon
see Figure). This in turn triggers activation of the EpoR- by demonstrating that JAK2 also enhances the surface
associated JAK2, which phosphorylates itself as well as expression of a chimeric protein comprising the extra-
the EpoR. An intriguing property of the EpoR is the cellular domain of the EpoR and the transmembrane and
inefficiency with which the newly synthesized receptors cytoplasmic domains of the prolactin receptor, another
are expressed at the cell surface, not only upon transfec- member of the cytokine receptor family functionally cou-
pled to JAK2 (Huang et al., 2001). It will now be of interesttion into nonhematopoietic cells but also in normal eryth-
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Schematic Representation of the Epo-EpoR-
JAK2 Complex
EpoR assembles with JAK2 in the ER, and
this assembly is required for optimal expres-
sion of the EpoR on the cell surface. Assem-
bly involves interaction of a membrane-proxi-
mal segment of the EpoR cytoplasmic
domain with the JH7 domain of JAK2. Binding
of Epo to the EpoR-JAK2 complex results in
JAK2 auto- or transphosphorylation as well
as phosphorylation of the EpoR kinase do-
main (P). The D1 and D2 domains of the EpoR
and JH3–JH7, pseudokinase and kinase do-
mains of JAK2 are indicated. Residues 32–
382 of JAK2 comprise a predicted FERM do-
main similar to those found in the cytoskeletal
adaptor proteins moesin and radixin.
to investigate whether other types of receptors that acti- National Institutes of Health
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other mitotic events are not appropriately coupled, un-Regulating Sister Chromatid
coordinated mitosis can take place, leading to errorsSeparation by Separase in chromosome transmission and aneuploidy. Recent
studies have made significant progress in understand-Phosphorylation
ing the molecular mechanism of sister chromatid sepa-
ration (Uhlmann et al., 1999; Nasmyth et al., 2000; Yana-
gida, 2000).
A recent paper in Cell highlights a second mechanism Sister chromatids duplicated during S phase are
of regulation of separase in addition to the bound in- closely connected to each other until anaphase. Sister
hibitor securin. This second pathway involves sepa- chromatid cohesion is set up during S phase, and the
rase phosphorylation and is dependent on CDC2. sister chromatids are linked by a protein complex named
cohesin.
Faithful transmission of chromosomes from mother to In vertebrates, dissociation of cohesin from chromo-
somes is a two-step process. The majority of the cohesindaughter cells is fundamental for genetic inheritance.
Separation of paired sister chromatids occurs during detaches during prophase, and the remainder is re-
moved in anaphase by cleavage of the cohesin subunitanaphase and needs to be properly coordinated to other
cell cycle events. If sister chromatid separation and SCC1/Rad21 by a cysteine protease called separase.
